<DOC>
	<DOCNO>NCT01354223</DOCNO>
	<brief_summary>This study seek evaluate new daily disposable contact lens compare exist daily disposable contact lens .</brief_summary>
	<brief_title>Clinical Evaluation Stenfilcon A Soft Contact Lens When Compared Ocufilcon B Soft Contact Lens</brief_title>
	<detailed_description>This study design evaluate stenfilcon A contact lens demonstrate substantial equivalence Ocufilcon B market release .</detailed_description>
	<criteria>Prior consider eligible participate study , subject MUST : Be least 18 year age date evaluation study . Have : Read Informed Consent give explanation Informed Consent indicate understand Informed Consent sign Informed Consent document . Be willing able adhere instruction set forth protocol able keep specified appointment . Be adapt , current fulltime silicone hydrogel soft contact lens wearer . An adapted fulltime wearer define wear contact lenses daily basis least 8 hour per day least one month prior participation study . Possess wearable visually functional eyeglass . Be good general health , base his/her knowledge . Require spectacle lens power 1.00 6.00 diopter sphere 1.00 diopter refractive astigmatism willing wear contact lenses eye . Have manifest refraction Snellen visual acuity ( VA ) equal good 20/25 eye . Upon complete fit process lens wear study , contact lens Snellen VA equal well 20/30 eye . Subjects may enrol study follow apply : The subject is/has : Wearing lens monovision modality unwilling fit distance lenses eye . NOTE : Subjects may wear lens monovision modality time study interfere visual acuity analysis . Poor personal hygiene . Any active participation another clinical trial within 30 day prior study . Currently pregnant ( best subject 's knowledge ) , lactate planning pregnancy within next 3 month . A member , relative household member investigator investigational office staff . Has know sensitivity ingredient use counter contact lens lubricant approve use study . Previous refractive surgery ; current previous orthokeratology treatment . Is aphakic psuedophakic . Ocular systemic disease , limited : anterior uveitis iritis ( past present ) , glaucoma , Sjögren 's syndrome , lupus erythematosus , sclerodermia , keratoconus type II diabetes . The need topical ocular medication medication might interfere contact lens wear would require lens remove day . The presence clinically significant ( grade 3 4 ) anterior segment abnormality ; inflammation iritis ; infection eye , lid , associate structure . A known history corneal hypoesthesia ( reduced corneal sensitivity ) , corneal ulcer , corneal infiltrates fungal infection . A history papillary conjunctivitis interfere contact lens wear . Slit lamp finding would contraindicate contact lens wear , include limited : Pathological dry eye associate dry eye symptom decrease tear level punctuate stain &gt; Grade 2 Pterygium Corneal scar within visual axis Neovascularization ghost vessel &gt; 1.0 mm limbus Giant papillary conjunctivitis ( GPC ) &gt; Grade 2 Anterior uveitis iritis Seborrheic eczema , seborrheic conjunctivitis blepharitis To eligible randomized study product subject must ALL Inclusion Criteria NONE exclusion criterion present . To eligible lens dispense ( either Test Control ) , subject 's study lens contact lens visual acuity must equal good 20/30 eye .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>silicone hydrogel contact lens</keyword>
	<keyword>SHCL</keyword>
	<keyword>stenfilcon A</keyword>
	<keyword>ocufilcon B</keyword>
	<keyword>daily disposable</keyword>
	<keyword>substantial equivalence</keyword>
	<keyword>CooperVision ClearSight™ 1 Day SCL</keyword>
</DOC>